Payment overview · 2025
General Payments
$296.87
17 reported records · 9 companies
Healthcare provider profile · identity verified
Timothy M Simon, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · MONTICELLO, AR · NPI 1376523316
Verified facts
What the public records show
CMS Open Payments records show Timothy M Simon, M.D. received $296.87 in general payments during 2025 across 17 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 18.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Farxiga, Ozempic, Trelegy Ellipta, Xifaxan.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 141 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 118 claims for Symbicort by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 90 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 358 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1198 claims for Eliquis by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $56.25 | 18.9% | 3 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $50.70 | 17.1% | 3 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $50.35 | 17.0% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $41.81 | 14.1% | 2 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $33.70 | 11.3% | 2 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $18.58 | 6.3% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $17.08 | 5.8% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $14.75 | 5.0% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $13.65 | 4.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $296.87 | 17 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $56.25 | 3 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $50.70 | 3 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $50.35 | 3 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $41.81 | 2 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $33.70 | 2 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $31.90 | 2 | 2025 |
Source payment records
|
|||||
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $18.58 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $18.45 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $17.08 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.75 | 1 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $13.65 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 1198 | exact normalized | Medicare Part D |
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 141 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 358 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 90 | exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
141 | 28 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
118 | 34 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
20 | 17 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
90 | 24 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
358 | 66 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1198 | 168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 2543 | 519 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2399 | 499 |
| Atorvastatin Calcium | Atorvastatin Calcium | 2315 | 495 |
| Losartan Potassium | Losartan Potassium | 2252 | 456 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2212 | 325 |
| Gabapentin | Gabapentin | 2101 | 400 |
| Potassium Chloride | Potassium Chloride | 1856 | 363 |
| Furosemide | Furosemide | 1753 | 321 |
| Glimepiride | Glimepiride | 1241 | 242 |
| Eliquis | Apixaban | 1198 | 168 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 998 | 258 |
| Tamsulosin Hcl | Tamsulosin Hcl | 977 | 189 |
| Tramadol Hcl | Tramadol Hcl | 958 | 280 |
| Metoprolol Succinate | Metoprolol Succinate | 955 | 218 |
| Metoprolol Tartrate | Metoprolol Tartrate | 950 | 195 |
| Metformin Hcl | Metformin Hcl | 907 | 207 |
| Hydrochlorothiazide | Hydrochlorothiazide | 882 | 172 |
| Lisinopril | Lisinopril | 878 | 189 |
| Omeprazole | Omeprazole | 818 | 191 |
| Citalopram Hbr | Citalopram Hydrobromide | 816 | 154 |
| Clopidogrel | Clopidogrel Bisulfate | 793 | 164 |
| Simvastatin | Simvastatin | 779 | 163 |
| Donepezil Hcl | Donepezil Hcl | 764 | 126 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 754 | 170 |
| Meloxicam | Meloxicam | 731 | 167 |
| Trazodone Hcl | Trazodone Hcl | 660 | 152 |
| Carvedilol | Carvedilol | 621 | 121 |
| Allopurinol | Allopurinol | 584 | 115 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 555 | 187 |
| Sertraline Hcl | Sertraline Hcl | 530 | 105 |
| Duloxetine Hcl | Duloxetine Hcl | 518 | 84 |
| Famotidine | Famotidine | 467 | 97 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 453 | 136 |
| Sucralfate | Sucralfate | 438 | 84 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 434 | 97 |
| Pregabalin | Pregabalin | 416 | 84 |
| Hydralazine Hcl | Hydralazine Hcl | 404 | 97 |
| Tizanidine Hcl | Tizanidine Hcl | 394 | 79 |
| Buspirone Hcl | Buspirone Hcl | 388 | 74 |
| Fluoxetine Hcl | Fluoxetine Hcl | 387 | 77 |
| Azithromycin | Azithromycin | 385 | 301 |
| Escitalopram Oxalate | Escitalopram Oxalate | 382 | 70 |
| Ozempic | Semaglutide | 358 | 66 |
| Methylprednisolone | Methylprednisolone | 349 | 288 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 341 | 88 |
| Quetiapine Fumarate | Quetiapine Fumarate | 339 | 64 |
| Clonidine Hcl | Clonidine Hcl | 338 | 80 |
| Xarelto | Rivaroxaban | 337 | 44 |
| Paroxetine Hcl | Paroxetine Hcl | 326 | 58 |
| Clonazepam | Clonazepam | 322 | 69 |
| Estradiol | Estradiol | 316 | 74 |
| Montelukast Sodium | Montelukast Sodium | 306 | 52 |
| Doxycycline Hyclate | Doxycycline Hyclate | 294 | 220 |
| Jardiance | Empagliflozin | 294 | 37 |
| Diclofenac Sodium | Diclofenac Sodium | 274 | 90 |
| Fluticasone Propionate | Fluticasone Propionate | 271 | 117 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 268 | 181 |
| Oxybutynin Chloride | Oxybutynin Chloride | 265 | 50 |
| Levetiracetam | Levetiracetam | 264 | 51 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 259 | 60 |
| Mirtazapine | Mirtazapine | 258 | 62 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 256 | 49 |
| Nifedipine Er | Nifedipine | 255 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 250 | 55 |
| Ropinirole Hcl | Ropinirole Hcl | 238 | 49 |
| Zolpidem Tartrate | Zolpidem Tartrate | 233 | 36 |
| Prednisone | Prednisone | 220 | 81 |
| Cefdinir | Cefdinir | 218 | 164 |
| Spironolactone | Spironolactone | 216 | 56 |
| Alprazolam | Alprazolam | 213 | 49 |
| Temazepam | Temazepam | 212 | 36 |
| Aripiprazole | Aripiprazole | 203 | 41 |
| Divalproex Sodium | Divalproex Sodium | 196 | 33 |
| Memantine Hcl | Memantine Hcl | 194 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 192 | 149 |
| Januvia | Sitagliptin Phosphate | 188 | 24 |
| Glipizide | Glipizide | 184 | 40 |
| Ondansetron Odt | Ondansetron | 184 | 72 |
| Atenolol | Atenolol | 179 | 35 |
| Celecoxib | Celecoxib | 175 | 48 |
| Ezetimibe | Ezetimibe | 175 | 41 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 172 | 35 |
| Finasteride | Finasteride | 170 | 38 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 168 | 23 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 167 | 30 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 164 | 142 |
| Propranolol Hcl | Propranolol Hcl | 162 | 27 |
| Ondansetron Hcl | Ondansetron Hcl | 155 | 65 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 151 | 42 |
| Methocarbamol | Methocarbamol | 151 | 69 |
| Risperidone | Risperidone | 150 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 147 | 29 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 147 | 38 |
| Topiramate | Topiramate | 145 | 24 |
| Warfarin Sodium | Warfarin Sodium | 142 | 25 |
| Farxiga | Dapagliflozin Propanediol | 141 | 28 |
| Latanoprost | Latanoprost | 141 | 34 |
| Olanzapine | Olanzapine | 141 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 138 | 27 |
| Entresto | Sacubitril/Valsartan | 136 | 27 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 134 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 132 | 23 |
| Mounjaro | Tirzepatide | 131 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 130 | 43 |
| Dicyclomine Hcl | Dicyclomine Hcl | 129 | 32 |
| Baclofen | Baclofen | 126 | 26 |
| Benztropine Mesylate | Benztropine Mesylate | 124 | 19 |
| Fluconazole | Fluconazole | 122 | 90 |
| Meclizine Hcl | Meclizine Hcl | 121 | 55 |
| Ventolin Hfa | Albuterol Sulfate | 121 | 44 |
| Bumetanide | Bumetanide | 118 | 32 |
| Symbicort | Budesonide/Formoterol Fumarate | 118 | 34 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 117 | 30 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 112 | 27 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 109 | 28 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 105 | 25 |
| Linzess | Linaclotide | 103 | 23 |
| Fenofibrate | Fenofibrate Nanocrystallized | 99 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 99 | 17 |
| Myrbetriq | Mirabegron | 99 | 16 |
| Verapamil Er | Verapamil Hcl | 97 | 22 |
| Cholestyramine | Cholestyramine (With Sugar) | 96 | 34 |
| Valsartan | Valsartan | 96 | 30 |
| Nystatin | Nystatin | 95 | 66 |
| Lorazepam | Lorazepam | 91 | 29 |
| Novolin R | Insulin Regular, Human | 91 | 31 |
| Tresiba Flextouch U-100 | Insulin Degludec | 91 | 19 |
| Alendronate Sodium | Alendronate Sodium | 90 | 21 |
| Metronidazole | Metronidazole | 90 | 72 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 90 | 24 |
| Doxazosin Mesylate | Doxazosin Mesylate | 89 | 20 |
| Primidone | Primidone | 89 | 15 |
| Promethazine Hcl | Promethazine Hcl | 88 | 27 |
| Synthroid | Levothyroxine Sodium | 87 | suppressed |
| Bupropion Xl | Bupropion Hcl | 86 | 20 |
| Ranolazine Er | Ranolazine | 86 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 82 | 19 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 82 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 78 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 77 | 21 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 76 | 13 |
| Digoxin | Digoxin | 76 | 17 |
| Lovastatin | Lovastatin | 76 | 19 |
| Clindamycin Hcl | Clindamycin Hcl | 72 | 66 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 72 | 18 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 70 | 21 |
| Carisoprodol | Carisoprodol | 68 | suppressed |
| Colchicine | Colchicine | 68 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 67 | 15 |
| Midodrine Hcl | Midodrine Hcl | 65 | 14 |
| Nitroglycerin | Nitroglycerin | 65 | 44 |
| Torsemide | Torsemide | 65 | 16 |
| Levofloxacin | Levofloxacin | 64 | 53 |
| Benazepril Hcl | Benazepril Hcl | 63 | suppressed |
| Chlorthalidone | Chlorthalidone | 63 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 62 | 30 |
| Labetalol Hcl | Labetalol Hcl | 62 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 60 | 16 |
| Bupropion Hcl | Bupropion Hcl | 59 | 12 |
| Lamotrigine | Lamotrigine | 58 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 56 | 12 |
| Haloperidol | Haloperidol | 56 | suppressed |
| Lansoprazole | Lansoprazole | 56 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 56 | 41 |
| Humalog Kwikpen U-100 | Insulin Lispro | 55 | 23 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 55 | 25 |
| Divalproex Sodium Er | Divalproex Sodium | 54 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 53 | 17 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 53 | 19 |
| Mupirocin | Mupirocin | 53 | 42 |
| Amoxicillin | Amoxicillin | 52 | 49 |
| Levemir | Insulin Detemir | 51 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 45 |
| Enalapril Maleate | Enalapril Maleate | 49 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 49 | suppressed |
| Novolog Flexpen | Insulin Aspart | 49 | 20 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 49 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 13 |
| Acyclovir | Acyclovir | 47 | 21 |
| Bupropion Hcl Sr | Bupropion Hcl | 46 | suppressed |
| Methimazole | Methimazole | 45 | suppressed |
| Naproxen | Naproxen | 44 | 11 |
| Gemfibrozil | Gemfibrozil | 43 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 42 | 11 |
| Cilostazol | Cilostazol | 41 | 14 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 41 | suppressed |
| Minoxidil | Minoxidil | 41 | suppressed |
| Glipizide Er | Glipizide | 40 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | 35 |
| Ramipril | Ramipril | 39 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 38 | suppressed |
| Humulin R | Insulin Regular, Human | 38 | suppressed |
| Zonisamide | Zonisamide | 38 | suppressed |
| Brilinta | Ticagrelor | 37 | suppressed |
| Calcitriol | Calcitriol | 36 | suppressed |
| Diazepam | Diazepam | 36 | 20 |
| Folic Acid | Folic Acid | 35 | suppressed |
| Klor-Con M20 | Potassium Chloride | 34 | 18 |
| Levemir Flexpen | Insulin Detemir | 34 | 13 |
| Oxcarbazepine | Oxcarbazepine | 33 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 33 | 11 |
| Metformin Hcl Er | Metformin Hcl | 32 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 32 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 32 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 31 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 31 | 12 |
| Dilt-Xr | Diltiazem Hcl | 30 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 30 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 30 | suppressed |
| Sotalol | Sotalol Hcl | 30 | suppressed |
| Dutasteride | Dutasteride | 29 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 29 | 16 |
| Methadone Hcl | Methadone Hcl | 29 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 29 | suppressed |
| Amantadine | Amantadine Hcl | 28 | suppressed |
| Lactulose | Lactulose | 28 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 27 | suppressed |
| Humalog | Insulin Lispro | 27 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 27 | suppressed |
| Clonidine | Clonidine | 26 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 26 | suppressed |
| Premarin | Estrogens, Conjugated | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 25 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 25 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 24 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 13 |
| Ibuprofen | Ibuprofen | 23 | 11 |
| Ketoconazole | Ketoconazole | 23 | 16 |
| Levetiracetam Er | Levetiracetam | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Novolog | Insulin Aspart | 23 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Tradjenta | Linagliptin | 23 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 22 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 22 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 21 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 20 | suppressed |
| Nabumetone | Nabumetone | 20 | suppressed |
| Ofloxacin | Ofloxacin | 20 | 18 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 20 | 17 |
| Terbinafine Hcl | Terbinafine Hcl | 20 | 13 |
| Varenicline Tartrate | Varenicline Tartrate | 20 | 14 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | 15 |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 19 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 19 | 19 |
| Prasugrel Hcl | Prasugrel Hcl | 19 | suppressed |
| Scopolamine | Scopolamine | 19 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 19 | suppressed |
| Famciclovir | Famciclovir | 18 | 18 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 18 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 18 | suppressed |
| Nystop | Nystatin | 18 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | 12 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Gemtesa | Vibegron | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 14 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | 13 |
| Desmopressin Acetate | Desmopressin Acetate | 16 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Indomethacin | Indomethacin | 14 | suppressed |
| Lacosamide | Lacosamide | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 14 | 14 |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Tacrolimus | Tacrolimus | 14 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Cefprozil | Cefprozil | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Erythromycin | Erythromycin Base | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Klayesta | Nystatin | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 13 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Azathioprine | Azathioprine | 12 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | 11 |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Silodosin | Silodosin | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $296.87 · 17 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, Dexcom G6 Transmitter, ELIQUIS, FARXIGA, Kerendia, NURTEC ODT, Omnipod, Ozempic, TRELEGY ELLIPTA, XIFAXAN, ZAVZPRET | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error